The infection route of COVID-19 involves introduction and infection in vivo when transmembrane protease, serine 2 (TMPRSS2) is cleaved after the spike protein of the COVID-19 virus binds to the angiotensin-converting enzyme 2 receptor. Here, TMPRSS2 is linked to infection.